38 SPXIQ

CRL Charles River Laboratories International, Inc.

Healthcare · Diagnostics & Research

$178.20 +10.7% upside
Mean Target
$197.20
Consensus
1.8 - Buy
Analysts
15
Rank
#421 / 499
Upside Rank
#248
Analyst Price Target Distribution
$155
Low
$193
Median
$197
Mean
$265
High
Current $178
Mean $197
Median $193
94 estimates
Consensus
1.8 - Buy
52-Wk Low
$91.86
52-Wk High
$228.88
50-Day Avg
$197.79
Recent Analyst Ratings
FirmRatingTargetPriorDate
UBS Neutral $175 $170 2026-02-25
TD Cowen Buy $235 $251 2026-02-20
Mizuho Neutral $175 $215 2026-02-20
Barclays Overweight $200 $215 2026-02-19
Evercore ISI Group Outperform $200 $260 2026-02-19
Healthcare Peers
ABT ABBV A ALGN AMGN BAX BDX TECH BIIB BSX BMY CAH CNC COR CI COO CVS DHR DVA DXCM EW ELV GEHC GILD